Aprotinin 2 million KIU reduces perioperative blood loss in patients undergoing primary total hip replacement

Japanese Journal of Anesthesiology

Volumn 46, Issue 1, 1997, Pages 80-82

  Utada, Kohji ^a   Matayoshi, Yasutoshi ^a   Sumi, Chieko ^a   Itaya, Miwa ^a   Miyawaki, Hiroshi ^a   Ito, Makoto ^a   Tamura, Hisashi ^a   Mitsukuji, Tsutomu ^a  

^a Gunma Cancer Center Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

ARTICLE; BLEEDING; GENERAL ANESTHESIA; HUMAN; POSTOPERATIVE PERIOD; SPINAL ANESTHESIA; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS;

AGED; APROTININ; BLOOD LOSS, SURGICAL; FEMALE; HEMOSTATICS; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; SINGLE-BLIND METHOD;

EID: 0031023021     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Royston D: High-dose aprotinin therapy: A review of the first five years' experience. Cardiothorac Vasc Anesth 6: 76, 1992
2. Royston D, Bidstrup BP, Taylor KM, et al: Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2: 1289, 1987
3. Royston D, Bidstrup BP, Taylor KM, et al: Aprotinin decreases the need for post-operative blood transfusions in patients having open heart surgery. Bibl Cardiol 43: 73, 1988
4. Bidstrup BP, Royston D, Sapsford RN, et al: Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Tradyrol). Thorac Cardiovasc Surg 97: 364, 1989
5. Janssens M, Joris J, David JL, et al: High dose aprotinin reduces blood loss in patients under-going total hip replacement surgery. Anesthe-siology 80: 23, 1994
6. Wollinsky KH, Mehrkens HH, Freytag T, et al: Vermindert Aprotinin den intraoperativen Blutverlust ? [German, English abstract]. Anasthesiol Intensivmed Notfallmed Schmertzther 26: 208, 1991
7. Murkin JM, Shannon NA, Bourne RB, et al: Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesthesiology 80: 343, 1995
8. Toy PTCY, Kaplan EB, McVay PA, et al: Blood loss and replacement in total hip arthroplasty: A multicenter study. Transfusion 32: 63, 1992
9. Van Oeveren W, Jansen NJG, Bidstrup BP, et al: Effects of aprotinin on haemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44: 640, 1987
10. Dietrich W, Spannagl M, Jochum M, et al: Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73: 1119, 1990
11. Haas S, Ketterl R, Stemberger A, et al: The effect of platelet function, blood coagulation and blood lactate level in total hip replacement -A double blind clinical trial. Adv Exp Med Biol 167: 287, 1984
12. Okumura T, Janieson GA: Platelet glycocalicin 1: Orientation of glycoproteins of the human platelet surface. J Biol Chem 251: 5944, 1976
13. Adelman B, Michelson AD, Loscalzo J, et al: Plasmin effect on platelet 1b - von Willebrand factor interactions. Blood 65: 32, 1985
14. Fritz H, Wunderer G :Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittel-Forschung Drug Res 33: 479, 1983
15. Beller FK, Epstein M, Kaller H: Distribution, half time and placental transfer of the protease inhibitor trasylol. Thromb Diath Haemorrh 16: 302, 1966
16. Levy AH: Unusual reaction to Trasyrol. Can Med Assoc J 111: 1304, 1974
17. Proud G, Chamberlain J: Anaphyractic reaction to aprotinin. Lancet 2: 48, 1976
18. Yanagihara Y, Shida T: Immunological studies on patients who received aprotinin therapy. Jpn J Allergol 34: 899, 1985
19. Kasper SM, Schmidt J: Is aprotinin worth the risk in total hip replasement ? To the editor. Anesthesiology 81: 517, 1994
20. Dodd RY: The risk of transfusion-transmitted infection. N Engl J Med 327: 419, 1992
21. Kretschmer V: Aktuelle Aspecte zur praoperativen Eigenblutspende von juristischer Tragweite (editorial). Infusionsther 19: 53, 1992